解放军医学院学报
解放軍醫學院學報
해방군의학원학보
Academic Journal of Chinese Pla Medical School
2015年
11期
1075-1077
,共3页
申少华%刘迎娣%王娟%高伟%吴文涛%孙国辉%杨竞%孙刚%孙潇%李萌
申少華%劉迎娣%王娟%高偉%吳文濤%孫國輝%楊競%孫剛%孫瀟%李萌
신소화%류영제%왕연%고위%오문도%손국휘%양경%손강%손소%리맹
自身免疫性肝硬化%乙型肝炎肝硬化%食管胃静脉曲张%内镜治疗%复发时间
自身免疫性肝硬化%乙型肝炎肝硬化%食管胃靜脈麯張%內鏡治療%複髮時間
자신면역성간경화%을형간염간경화%식관위정맥곡장%내경치료%복발시간
autoimmune cirrhosis%hepatitis B cirrhosis%esphagogastric varices%endoscopic therapy%recurrence time
目的：探讨自身免疫性肝硬化与乙型肝炎肝硬化合并食管胃静脉曲张内镜治疗后复发的临床特点。方法回顾性分析2006-2013年在解放军总医院消化内科行内镜下治疗的20例自身免疫性肝硬化合并食管胃静脉曲张患者治疗后复发的临床特点，并与同期住院的43例乙肝肝硬化合并食管胃静脉曲张患者的第1次内镜下治疗次数及治疗后复发时间进行对比。结果自身免疫性肝硬化和乙肝肝硬化患者第1次内镜治疗平均次数分别为2.10±1.25次和2.93±1.20次，两者差异有统计学意义(P＜0.05)，而且自身免疫性肝硬化复发时间较乙肝肝硬化提前(P＜0.05)，分别为0.70±0.44年和1.22±0.97年。结论内镜治疗后自身免疫性肝硬化较乙型肝炎肝硬化更早复发。
目的：探討自身免疫性肝硬化與乙型肝炎肝硬化閤併食管胃靜脈麯張內鏡治療後複髮的臨床特點。方法迴顧性分析2006-2013年在解放軍總醫院消化內科行內鏡下治療的20例自身免疫性肝硬化閤併食管胃靜脈麯張患者治療後複髮的臨床特點，併與同期住院的43例乙肝肝硬化閤併食管胃靜脈麯張患者的第1次內鏡下治療次數及治療後複髮時間進行對比。結果自身免疫性肝硬化和乙肝肝硬化患者第1次內鏡治療平均次數分彆為2.10±1.25次和2.93±1.20次，兩者差異有統計學意義(P＜0.05)，而且自身免疫性肝硬化複髮時間較乙肝肝硬化提前(P＜0.05)，分彆為0.70±0.44年和1.22±0.97年。結論內鏡治療後自身免疫性肝硬化較乙型肝炎肝硬化更早複髮。
목적：탐토자신면역성간경화여을형간염간경화합병식관위정맥곡장내경치료후복발적림상특점。방법회고성분석2006-2013년재해방군총의원소화내과행내경하치료적20례자신면역성간경화합병식관위정맥곡장환자치료후복발적림상특점，병여동기주원적43례을간간경화합병식관위정맥곡장환자적제1차내경하치료차수급치료후복발시간진행대비。결과자신면역성간경화화을간간경화환자제1차내경치료평균차수분별위2.10±1.25차화2.93±1.20차，량자차이유통계학의의(P＜0.05)，이차자신면역성간경화복발시간교을간간경화제전(P＜0.05)，분별위0.70±0.44년화1.22±0.97년。결론내경치료후자신면역성간경화교을형간염간경화경조복발。
Objective To investigate the recurrence time of gastroesophageal varices after endoscopic treatment in patients with autoimmune cirrhosis or hepatitis B cirrhosis.Methods Clinical features of 20 patients with gastroesophageal varices with autoimmune cirrhosis who were conducted with endoscopic treatment in our hospital from 2006 to 2013 were retrospectively analyzed, and their mean number forfirst endoscopic treatment and recurrence time after treatment were compared with 43 patients with hepatitis B cirrhosis in our hospital during the same period.ResultsCompared with patients with hepatitis B cirrhosis, the mean number offirst endoscopic treatment in patients with autoimmune cirrhosis was significantly less [(2.93±1.20)vs (2.10±1.25), P<0.05], and the recurrence time of autoimmune cirrhosis was significantly earlier [(0.70±0.44) vs (1.22±0.97),P<0.05]. Conclusion Compared with patients with hepatitis B cirrhosis, patients with autoimmune cirrhosis relapse earlier after endoscopic treatment.
